XenoPort (NXPT) Includes Gabapentin Enacarbil in RLS/WED Treatment – StreetInsider.com (subscription)

by admin on September 11, 2013

XenoPort (NXPT) Includes Gabapentin Enacarbil in RLS/WED Treatment
StreetInsider.com (subscription)
XenoPort, Inc. (Nasdaq: XNPT) announced the inclusion of gabapentin enacarbil, the active ingredient in HORIZANT (gabapentin enacarbil) Extended-Release Tablets, as an initial therapy for chronic persistent restless legs syndrome/Willis-Ekbom disease 

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: